Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
CALL
Virgin Galactic
SPCE
$503M
| $5.36M | ﹤0.01% |
66,225
-104,530
| -61% | -$10.4M |
|
3627
Ligand Pharmaceuticals
LGND
$5.87B
| $5.36M | ﹤0.01% |
72,857
-80,071
| -52% | -$5.69M |
|
3628
CALL
Cal-Maine
CALM
$3.8B
| $5.36M | ﹤0.01% |
88,000
-43,300
| -33% | -$2.42M |
|
3629
CALL
Teleflex
TFX
$5.81B
| $5.34M | ﹤0.01% |
21,100
-30,400
| -59% | -$7.37M |
|
3630
Insperity
NSP
$1.99B
| $5.34M | ﹤0.01% |
43,942
-36,378
| -45% | -$4.25M |
|
3631
Invesco NASDAQ 100 ETF
QQQM
$104B
| $5.34M | ﹤0.01% |
40,437
+40,108
| +12,191% | +$4.87M |
|
3632
PUT
Synaptics
SYNA
$4.25B
| $5.34M | ﹤0.01% |
48,000
+5,000
| +12% | +$576K |
|
3633
TTEC Holdings
TTEC
$77.9M
| $5.33M | ﹤0.01% |
143,215
+94,787
| +196% | +$4.24M |
|
3634
CALL
Axcelis
ACLS
$4.33B
| $5.33M | ﹤0.01% |
40,000
+15,600
| +64% | +$1.83M |
|
3635
PUT
Barclays
BCS
$94.7B
| $5.33M | ﹤0.01% |
741,100
+420,100
| +131% | +$3.47M |
|
3636
PUT
CSX Corp
CSX
$92.9B
| $5.33M | ﹤0.01% |
177,900
-163,600
| -48% | -$5.03M |
|
3637
PUT
ATI
ATI
$31.1B
| $5.32M | ﹤0.01% |
134,900
-67,800
| -33% | -$2.56M |
|
3638
CALL
Vista Energy
VIST
$7.56B
| $5.31M | ﹤0.01% |
268,300
+169,800
| +172% | +$2.91M |
|
3639
Navios Maritime Partners
NMM
$2.33B
| $5.31M | ﹤0.01% |
220,057
+25,296
| +13% | +$653K |
|
3640
Domo
DOMO
$184M
| $5.31M | ﹤0.01% |
373,856
+73,555
| +24% | +$1.04M |
|
3641
Atea Pharmaceuticals
AVIR
$411M
| $5.3M | ﹤0.01% |
1,581,708
+975,523
| +161% | +$3.96M |
|
3642
SM Energy
SM
$8.03B
| $5.3M | ﹤0.01% |
188,127
-190,575
| -50% | -$5.81M |
|
3643
Schwab Fundamental International Small Company Index ETF
FNDC
$3.18B
| $5.29M | ﹤0.01% |
+159,822
| New | +$5.24M |
|
3644
PUT
Lumentum
LITE
$82.1B
| $5.29M | ﹤0.01% |
98,000
-53,600
| -35% | -$2.99M |
|
|
GTLS.PRB
3645
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
| – | – |
-300,000
| Closed | -$16.4M |
|
3646
CALL
Champion Homes
SKY
$5.13B
| $5.29M | ﹤0.01% |
70,300
+59,900
| +576% | +$3.86M |
|
3647
CALL
Vertiv
VRT
$113B
| $5.27M | ﹤0.01% |
368,400
+321,100
| +679% | +$4.71M |
|
3648
KBR
KBR
$4.84B
| $5.27M | ﹤0.01% |
95,734
-52,492
| -35% | -$2.75M |
|
|
DAWN
3649
DELISTED
Day One Biopharmaceuticals
DAWN
| $5.27M | ﹤0.01% |
394,084
+387,213
| +5,635% | +$7.56M |
|
3650
MaxLinear
MXL
$7.69B
| $5.27M | ﹤0.01% |
149,627
-109,623
| -42% | -$3.97M |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.